Peptides & Modern Research

What peptides are, how natural, synthetic and modified peptides differ, how they relate to proteins, and why the word on a label can mean very different things.

Why no single length cutoff separates peptides from proteins, how the NIH, FDA and reviews each draw the line, and what that means when you read a product or study.

How peptides differ from single amino acids, how the body digests and absorbs each, and why an amino acid supplement is not a peptide product or the reverse.

How amino acids are joined by peptide bonds, what an amino acid sequence is, and why a one-position change or a chemical tweak can make a different molecule.

The difference between peptides the body makes and peptides given as medicines or products, and why finding a peptide in the body does not show that taking it is safe or…

How natural, chemically synthesized, recombinant and chemically modified peptides differ, with approved-medicine examples, and why origin alone does not decide safety.

Hormones and peptides overlap but are not the same group: some hormones are peptides, some are steroids or other molecules, and many peptides are not hormones.

A plain-language guide to how cells receive signals through receptors, how peptides bind them as activators or blockers, and why binding alone does not prove a health be…

What agonist and antagonist mean for peptide hormones and medicines, with label examples such as semaglutide, tirzepatide, leuprolide and degarelix, and why the word alo…

How peptidase enzymes break peptides apart in the gut, blood and organs, and how medicine makers slow that down, with DPP-4 and GLP-1 as the worked example.

What half-life and clearance mean for peptides, with label values from natural hormones to semaglutide, why longer is not simply better, and why one number does not tran…

What bioavailability means, why peptides taken by mouth reach the blood in tiny amounts, and how label figures differ by product and route for semaglutide, desmopressin …

How small changes in a peptide's sequence, D-amino acids, side chains and salt form change what it does, using label examples such as leuprolide, octreotide and desmopre…

Why products with similar peptide names can differ in molecule, fragment, salt form, formulation or approval status, with TB-500, CJC-1295 and semaglutide examples from …

Why a proposed mechanism, a lab marker or an animal result is not a demonstrated clinical benefit, with examples from MK-677, CJC-1295 and BPC-157 and a checklist for re…

An A-Z directory of peptide medicines, natural signaling molecules, cosmetic ingredients and research compounds, each with a status label and an evidence label.

How to read an entry in the peptide directory: the difference between a molecule, brand and formulation, and what the status and evidence labels do and do not mean.

A plain-language class overview of prescription GLP-1 medicines (semaglutide, tirzepatide, liraglutide, dulaglutide): US label uses, trial results, boxed warning and saf…

A class overview of approved insulin, GLP-1, dual-agonist and amylin-analogue medicines for diabetes and weight, with US label uses, safety warnings and what each class …

Overview of approved peptide medicines that act on bone and calcium: teriparatide, abaloparatide, calcitonin salmon and palopegteriparatide, with US label uses, trials a…

Overview of approved gut peptide medicines: linaclotide and plecanatide for constipation conditions and teduglutide for short bowel syndrome, with US label uses, trials …

Overview of approved hormone-peptide medicines: desmopressin, oxytocin, GnRH agonist leuprolide and the somatostatin analogue octreotide, with US label uses, trials cont…

A guide to approved peptide medicines outside the main classes: ziconotide, setmelanotide, glucagon, icatibant and bremelanotide, with US label uses, trial context and s…

Ozempic vs Wegovy and similar pairs explained: how active ingredient, brand, formulation and approved indication differ, with US and EU label examples and what off-label…

Semaglutide is a GLP-1 receptor agonist sold under several brands; this overview covers what US and EU regulators approved it for, the main trials, and the label safety …

Tirzepatide acts on both GIP and GLP-1 receptors and is sold as Mounjaro and Zepbound; this overview covers label indications, key trials and safety information from the…

Liraglutide is a daily GLP-1 receptor agonist sold as Victoza for type 2 diabetes and Saxenda for weight; this overview covers label indications, key trials and safety i…

Dulaglutide (Trulicity) is a once-weekly GLP-1 receptor agonist built as a fusion protein; this overview covers label indications, the REWIND heart trial and main safety…

Exenatide and lixisenatide are older GLP-1 medicines for type 2 diabetes; this overview covers their identity, label indications, EU withdrawals and main safety informat…

Pramlintide (brand Symlin) is an amylin analogue approved in the US as an add-on for people with diabetes who use mealtime insulin; this page covers label indications, t…

A plain-language class overview of human insulin and rapid- and long-acting insulin analogues, using FDA labels for Humalog, Lantus and Novolin R, with safety points and…

Teriparatide (Forteo) and abaloparatide (Tymlos) are bone-building injectable medicines for osteoporosis; this page covers label indications, fracture trials, osteosarco…

Calcitonin salmon is an approved injectable and nasal medicine for bone and calcium conditions; this page covers US labels, the EU restriction on osteoporosis use and th…

Linaclotide (Linzess) and plecanatide (Trulance) are oral guanylate cyclase-C agonist peptides approved for constipation conditions; this page covers labels, trial resul…

Teduglutide (Gattex in the US, Revestive in the EU) is a GLP-2 analogue approved for short bowel syndrome; this page covers label indications, trial results, growth-rela…

Desmopressin is a lab-made version of the hormone vasopressin. See its US label uses, what trials show for bedwetting and night-time urination, and the sodium risk.

Oxytocin is a body hormone and a hospital medicine for labor and bleeding after birth. See the US label, the risks, and why autism trials of nasal oxytocin found no bene…

GnRH agonists such as leuprolide and antagonists such as cetrorelix, ganirelix and degarelix are approved peptide medicines. Their label uses, mechanisms and safety info…

Octreotide and lanreotide are lab-made versions of the hormone somatostatin. What the US labels approve them for, the trial evidence, and the main safety information.

Tesamorelin (Egrifta) is an FDA-approved growth-hormone-releasing-hormone analogue for excess belly fat in HIV lipodystrophy, not weight loss or anti-aging. Label facts …

Bremelanotide (PT-141) is the ingredient in the FDA-approved medicine Vyleesi for low sexual desire in some premenopausal women. Label limits, trial results and safety f…

BPC-157 is an unapproved research peptide promoted for injury recovery. What animal and human studies show, what regulators and sport bodies say, and what remains unknow…

Why "TB-500" and thymosin beta-4 are not the same thing: what the name refers to, what human research exists, and how regulators and sport bodies treat each.

Sermorelin, CJC-1295, ipamorelin and tesamorelin compared: how they act on growth hormone, what trials show, which is an approved medicine, and the risks regulators desc…

What is known about Semax and Selank, two peptides studied in small, mostly Russian trials, covering small human trials, lab findings, FDA's safety concerns and the limi…

Thymosin beta-4 is a 43-amino-acid peptide the body makes. What it does, how it has been studied as a medicine, what trials show, and how it differs from TB-500 products.

CJC-1295 is a growth-hormone-releasing-hormone analogue studied in small early trials. Why "with DAC" and "without DAC" products are not interchangeable, what trials sho…

Ipamorelin is a five-amino-acid ghrelin-receptor agonist. What its one published phase 2 trial found, what regulators and sport bodies say, and what remains unproven.

Sermorelin is a 29-amino-acid fragment of growth-hormone-releasing hormone. This page covers its past FDA-approved uses, what trials showed, safety notes and current sta…

GHRP-2, GHRP-6 and hexarelin are three synthetic ghrelin-receptor peptides. Here is what is known about identity, diagnostic use, trials, safety and regulatory status.

GHK-Cu is a copper-binding tripeptide used in skincare. This page separates its identity, cosmetic and injectable claims, human trials, safety and regulatory status.

Thymosin alpha-1 (thymalfasin) is a thymic peptide studied for sepsis, hepatitis and infections. See the trial evidence, safety notes and regulatory picture.

AOD-9604 is a synthetic fragment based on the tail of human growth hormone, studied for obesity. See its identity, the thin human evidence, FDA, sport and safety notes.

MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA. See what mouse and early human data show, current trials, FDA and sport status, and the unknowns.

Humanin is a small peptide made by mitochondrial DNA. Here is what lab, animal and human studies show, why it is not a medicine, and what we could not verify.

SS-31 is the research name for elamipretide, a four-amino-acid peptide. FDA granted it accelerated approval in 2025 for Barth syndrome; other uses are still investigatio…

Epitalon (epithalon) is a synthetic four-amino-acid peptide promoted for aging and sleep. See what lab, animal and small human studies show, and what FDA said in 2026.

Semax is a short peptide registered as a prescription nasal drug in Russia but not approved in the US. See the small Russian trials, lab findings, FDA's 2026 review and …

Selank is a short peptide related to tuftsin, registered in Russia as a nasal anxiolytic. See the small Russian trials, lab work, what FDA says, and the evidence gaps.

What research and regulators say about KPV and LL-37, two promoted peptides, plus a short guide to other substances on FDA's compounding warning list and where to read a…

Melanotan is a name for lab-made hormone look-alikes sold as tanning injections and sprays; this page covers what they are, case reports, product tests and regulator war…

MK-677 (ibutamoren) is a small-molecule pill that raises growth hormone, not a peptide; this page covers trial results, risks, regulator warnings and anti-doping status.

Why the name on a "research peptide" product may not match the molecule in a published study, with sourced examples (TB-500, CJC-1295, melanotan, MK-677) and product-tes…

How the gut hormones GLP-1 and GIP work in the body, what the incretin effect is, and why this biology is not the same thing as the clinical results of medicines.

What the body's own hormones glucagon and amylin do, how they relate to GLP-1, and how this biology differs from the medicines and research compounds built on them.

How gut and pancreatic hormones signal fullness and control how fast the stomach empties, and why hormone biology does not by itself show a product helps with appetite o…

Which clinical outcomes trials of GLP-1 and GIP-based medicines have measured, from weight and blood sugar to heart events, with the limits and drug-specific differences.

How growth hormone and IGF-1 are made and controlled, what the GH-IGF-1 axis does, and why higher levels are not automatically better for health.

What ghrelin is, how it triggers growth hormone release and appetite, and what the term growth hormone secretagogue means, kept separate from any product claims.

Why a higher or lower lab number is not the same as feeling or living better, using IGF-1, surrogate endpoints and GH research as plain examples.

What thymic peptides are, how the thymus shapes immune signaling, and what human trials of thymosin alpha-1 and thymosin beta-4 do and do not show, with regulator statem…

A plain guide to cytokines as an adjacent protein-signaling field: why raising or blocking one signal helps in one condition and harms in another, shown with FDA labels …

How new blood vessels form, why growing vessels helps in some diseases and fuels others, and what labels and trials show for VEGF blockers, repair growth factors and pro…

How inflammation and the scaffold around cells (the extracellular matrix) signal each other in repair, scarring and skin ageing, and what human evidence exists for matri…

How mitochondria send signals, what mitochondrial-derived peptides such as humanin and MOTS-c are, how they differ from the synthetic drug elamipretide, and what human e…

Why healing in cells, rodents and tendon injury models does not equal human recovery, with meta-research, regulator label limits and peptide examples, and how to read a …

An overview of skin-care peptides such as GHK-Cu, Matrixyl and Argireline: names versus molecules, what studies show, cosmetic versus drug claims, and what is unproven.

What cosmetic peptides are, how they differ from drugs, the main ingredient types, what kind of evidence usually backs them, and how to read a label without hype.

Why getting a peptide into skin and keeping it intact in a cream is hard, what laboratory studies show about penetration and breakdown, and why a clever formula is not p…

Why a study of a peptide ingredient does not prove a serum works, and why a study of a finished serum does not prove the peptide inside it is responsible.

How cosmetic peptide families (signal, carrier, neurotransmitter-affecting, enzyme-inhibitor and copper peptides) are defined, which ingredient names belong where, and h…

A claim check on "botox-like" skincare peptides such as acetyl hexapeptide-8: what the idea is, what trials and penetration studies show, and how they differ from botuli…

Palmitoyl pentapeptide-4 (Pal-KTTKS, often sold as Matrixyl) is a skincare signal peptide; this page separates its names and reviews the small trials and the safety asse…

Palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7 are two skincare peptides often sold together as Matrixyl 3000; this page covers their identity, evidence gaps and sa…

Acetyl hexapeptide-8, sold as Argireline, is a skincare peptide called "botox-like"; this page covers its names, the small trials, penetration studies and safety review.

A guide to other documented cosmetic peptide ingredients beyond the main ones, with label names, how much evidence each has, and what safety reviews exist.

What published studies report for peptide creams and serums on fine lines, hydration and skin barrier measures, and why most results are small, short and tied to finishe…

A claim check on peptide hair serums and treatments: what lab work, branded-ingredient trials and standard hair-loss care show, and where proper human evidence is missin…

What is known about irritation and allergy with peptide skincare, why preservatives and fragrance matter as much as the peptide, and how cosmetics are overseen in the Un…

A plain comparison of cosmetic peptides and retinoids such as retinol and tretinoin for photoaged skin: how much research each has, what it shows, and how irritation and…

A plain comparison of cosmetic peptides and topical vitamin C (ascorbic acid) for wrinkles, pigmentation and hydration, with what each has been shown to do and where evi…

A short guide to collagen peptides, protein hydrolysates and food-derived bioactive peptides: what reviews show for skin, joints and blood sugar, and where evidence is t…

How the body breaks dietary protein into amino acids and small peptides, how those pieces are absorbed, and why a peptide in a food does not equal an effect in the body.

What hydrolyzed proteins are, how they are made, what trials show for blood sugar and infant formulas, and why allergy and label questions matter.

Milk-derived peptides from casein and whey: the lactotripeptide blood-pressure trials, what the evidence shows, and the gap between milk research and powdered products.

Marine-derived peptides from fish, shellfish and mollusks: what lab research claims, what the few human trials of fish and marine protein hydrolysates found, and the all…

How fermentation can release peptides in foods like fermented milk, what human trials show, the biogenic amine and allergy caveats, and why a fermented food is not a pep…

Why finding a bioactive peptide in a food does not show a health effect from eating it: digestion, absorption, the gap from lab to people, and how to read food-peptide c…

Why studies of peptides in foods do not automatically apply to concentrated peptide supplements, and the reverse: how to compare food, hydrolysate and supplement evidenc…

Why many peptides do not survive the gut intact, how the body absorbs the small pieces, and why a peptide that works in a lab dish may not work when swallowed.

How a few approved peptide medicines, such as oral semaglutide and oral octreotide, are formulated to get a small share of the drug through digestion, as the labels desc…

The science of how peptides given under the skin are absorbed, why absorption varies, and how drug design stretches duration, with no injection technique.

What intravenous (into a vein) delivery means for peptide drugs, why it skips absorption, how fast peptides can clear, and why sterility matters most here.

What is known about peptides sprayed into the nose, including approved nasal sprays that act in the body, the debate over nose-to-brain delivery, and why brain claims ne…

A claim check on peptides applied to the skin: why the skin barrier limits penetration, what delivery technologies exist, and how cosmetic and drug rules differ.

How depot and extended-release peptide medicines are designed to release a drug slowly, what a leuprolide depot label shows, and why the formulation is part of the medic…

How chemists modify peptides with fatty acids, polyethylene glycol and ring structures to last longer or resist breakdown, with approved-medicine examples and limits.

What liposomes, nanoparticles and other encapsulation do for drugs, which approved products exist, and why "liposomal" on a label does not by itself mean a peptide works.

The chemistry behind why peptide drugs lose potency or clump, which factors drive it, and why stability is a manufacturing and regulatory question, not a home-handling g…

Why the immune system sometimes makes antibodies against peptide medicines, how impurities and PEG add to the risk, what a semaglutide label reports, and why a test resu…

Why blood levels, half-life and hormone changes do not by themselves show that a peptide helps people, with label examples from semaglutide and leuprolide.

What trials show for peptide medicines in diabetes (GLP-1 drugs, tirzepatide, insulin analogues), with design, size and funding, and what is missing for unapproved pepti…

Trial evidence for approved peptide weight-management medicines (semaglutide, tirzepatide), their label warnings, and why promoted or compounded "weight loss peptides" a…

Outcome trials of GLP-1 and GIP/GLP-1 medicines (LEADER, SUSTAIN-6, SELECT, FLOW, SURPASS-CVOT): who was studied, what was measured, what went wrong, and what is unknown…

A claim check on peptides for muscle growth and physical function: what trials of growth hormone, MK-677, tesamorelin and GLP-1 drugs found, and why hormone levels are n…

A claim check on BPC-157, thymosin beta-4 and TB-500 for tendon and ligament injury: mostly animal work, a few tiny human reports, no approved product, and sport and FDA…

Evidence on peptides for wound healing: topical thymosin beta-4 in ulcer trials, GHK-Cu's mostly preclinical record, no human studies of TB-500, and when to see a clinic…

Approved peptide medicines for gut conditions (linaclotide, teduglutide) compared with promoted BPC-157 and ipamorelin, with trial design, size, outcomes, safety and FDA…

Which peptides have real evidence for bone health: two approved osteoporosis medicines with fracture trials, and promoted peptides that so far have only animal data.

What research shows for peptides marketed for immunity, from thymosin alpha-1 trials in sepsis, COVID-19 and hepatitis B to KPV, plus approved peptide medicines for spec…

What human studies show for peptides studied in memory, stroke, dementia, anxiety and autism, including Semax, Selank, Cerebrolysin, a GHRH analog, semaglutide and oxyto…

What small trials and reviews show for cosmetic peptides on wrinkles and hydration, what is known about peptides and hair, and how cosmetic rules and injectable claims d…

What the evidence shows for elamipretide in Barth syndrome and mitochondrial myopathy, and for the mitochondria-linked peptides MOTS-c and humanin, with the FDA accelera…

A claim check on peptides marketed for anti-aging and longevity, covering epitalon, growth-hormone-releasing peptides and mitochondrial peptides, and why a biomarker cha…

Approved versus promoted peptides for sexual and reproductive health: bremelanotide (PT-141) trials and label, oxytocin, kisspeptin research, and Melanotan II warnings, …

How small-molecule drugs, peptides, antibodies, RNA and gene-based therapies differ in size and behavior, and why a short summary cannot rank them.

A short, plain summary of stem cell, exosome and platelet-rich plasma research, what regulators warn about, and how it differs from peptide products.

What peptide-drug conjugates, antibody-drug conjugates and targeted nanoparticles are, what stage the research is at, and why targeting in theory is not proof in people.

How computer design, AI, protein structure prediction and lab-grown organoids are used in peptide research, and why a promising platform is not proof that a treatment wo…

A guide to where peptide-adjacent topics are covered on this site: aging research, biohacking, consumer devices, and cell, gene and molecular therapies.

A plain overview of peptide safety: why risk differs by product, what regulators say about unapproved injectables, and where to read more on allergy, infection, endotoxi…

What safety evidence an approved peptide medicine has that an experimental or compounded product usually lacks, and why a brand, a molecule and a formulation are not int…

Why "no side effects were reported" in a short peptide study does not establish long-term safety, with examples of what is known, what is unknown and how to read the gap.

How peptide products can trigger allergic reactions and anti-drug antibodies, what the tesamorelin label shows, and why impurities in unregulated products add uncertaint…

Why injected products carry infection risks that other products do not, what warning signs need urgent care, and what regulators say, without any injection technique or …

Purity, sterility and endotoxin are three different questions about an injectable product. A purity figure does not show it is sterile or endotoxin-free; here is what ea…

What testing of peptide products bought online and regulator reviews show about wrong amounts, impurities, endotoxin and unverified identity, and why a label cannot be t…

What FDA and WHO have said about counterfeit and falsified semaglutide, products arriving warm, and fake pharmacy labels, and why cold-chain and authenticity claims cann…

What a certificate of analysis is, what a purity percentage can and cannot tell you, and what studies and FDA say about peptide products sold with test reports.

Why safety of combining experimental peptides cannot be assumed, what is and is not known, and what regulator labels show about interactions even for approved peptide me…

What FDA labels say about pregnancy and breastfeeding for approved peptide medicines, and why promoted peptides without human data cannot be called safe in pregnancy.

Which peptide medicines have FDA-labeled use in adolescents, which do not, and why promoted peptides sold online have no established safety for children and teens.

What US labels say about kidney and liver function for specific peptide medicines (GLP-1 drugs, teriparatide, tesamorelin, mecasermin), and where no evidence was found f…

Cancer-related warnings are different for each peptide medicine. Label facts for GLP-1 drugs, teriparatide, tesamorelin and mecasermin, and what is not known for unappro…

Compound-specific examples of drug interactions from US labels for GLP-1 drugs, tirzepatide, teriparatide and tesamorelin, with no universal chart and no advice to stop …

How people in the United States can report a bad reaction or product-quality problem with a peptide medicine or unapproved peptide product to FDA MedWatch, and what is n…

Warning signs after a peptide medicine or unapproved peptide product that need emergency care or a same-day call, with verified US emergency numbers and what to tell res…

What approved, investigational and unapproved mean for peptide products, with US FDA and anti-doping examples, compounding limits and why a research-use-only label does …

What the US FDA says about compounded, counterfeit and "research use" GLP-1 products, the safety concerns it lists, a market study of online semaglutide and how to repor…

A plain checklist for judging peptide clinic and online marketing: approval status, animal versus human evidence, research-use-only labels, compounding, trial registrati…

What it means when a regulator approves a medicine, how approval differs from fast track or breakthrough designation, expanded access and compounding, with US FDA and EU…

Plain definitions of approved, off-label, investigational, expanded-access and unapproved use of a medicine, with US FDA sources and peptide examples, and questions to a…

How clinical trial phases work, what a registry entry for a peptide study does and does not show, and why registered studies are not results, using FDA, WHO and Clinical…

What drug compounding is and is not in the United States: sections 503A and 503B, bulk-substance rules, quality standards, FDA's safety-risk list and why compounding is …

What "research use only" and "not for human consumption" labels mean on peptide products, what US regulators have said about them, and why the label does not make a prod…

Which peptide medicines are prescription-only, what a prescription does and does not mean for compounded or unapproved products, and what US and UK regulators say, with …

What the US FDA and UK MHRA say about importing medicines for personal use and supplying unapproved peptide products, with the limits of what could be verified.

What FDA warning letters, compounding safety-risk lists and public alerts say about unapproved peptide products, read from the regulators, with no seller or brand names.

How the WADA Prohibited List treats named peptides such as BPC-157, TB-500, CJC-1295 and ipamorelin, why status depends on the compound and not marketing, and what chang…

A plain educational overview of therapeutic use exemptions (TUEs) in sport, who grants them, the four criteria, and why a TUE for an experimental peptide is unlikely.

How peptides and anabolic steroids differ in chemistry, medical use, evidence, risks and legal context, and why "peptide" is not a safer-sounding word for the same thing.

How growth hormone itself differs from growth-hormone-releasing peptides, what each is approved for, and what trials in healthy people have and have not shown.

Why swallowed and injected peptide products are not interchangeable, using the oral and injectable semaglutide labels as a worked example, with no use instructions.

What regulator approval requires, what evidence typically sits behind research peptides, and how to read a claim that a peptide is "backed by research."

How compounded drugs differ from FDA-approved ones in review, quality standards and oversight, with regulator warnings about compounded GLP-1 and other peptide products.

Why swallowed collagen peptides and experimental injectable peptides such as BPC-157 share a word but not a category, an evidence base or a risk profile.

GHK-Cu appears in creams and in products sold for injection. What the research covers for each route, what it does not, and how regulators treat them differently.

Thymosin beta-4 is a molecule the body makes; "TB-500" is a market name for a shorter fragment. How they differ in identity, human evidence, regulation and sport rules.

What separates a GLP-1 medicine from a dual GIP/GLP-1 agonist: targets, labels, head-to-head trials and limits, without declaring a winner.

Semaglutide and tirzepatide compared from their U.S. labels and head-to-head trials: indications, shared warnings, differences in evidence, and why there is no universal…

Claim check on "peptides heal any injury": what the claim says, what human and animal evidence exists for BPC-157, TB-500, thymosin beta-4 and GHK-Cu, and where it stops.

Claim check on "peptides are natural, so they are safe": why the body making a molecule does not make a product safe, with label, regulator and review evidence.

What "research grade" on a peptide label means, what it does not mean, and what regulators and testing studies say about research-labeled products sold for human use.

What a "99% purity" figure on a peptide can and cannot show, with findings from testing studies and what FDA says about contamination, sterility and compounded drugs.

Checks the claim that peptides reverse aging: what human trials and reviews show, what is only animal or cell research, and what approved peptide medicines are actually …

Checks the claim that peptides have no side effects: what labels, regulators and small human studies report, and why "none reported" is not the same as "none".

What "clinically proven" should mean for a peptide, how to match the claim to a real human trial, and what the human evidence for BPC-157 and epitalon looks like.

Checks the idea that a peptide must be approved because a doctor or clinic offers it: what FDA says about compounded and unapproved drugs, and questions that separate ap…

How to read peptide research: what cell, animal, early human, large trial and review evidence can and cannot show, and why a changed lab marker is not the same as a bett…

Where to look for published peptide studies, trial registrations, regulator records and anti-doping lists, and how to read what you find without overstating it.

Plain-language definitions of about 65 terms used in peptide science, medicine, product quality, regulation and research, explained for understanding only.